Skip to main content
· 1/13/2014

Williamson v. Albany Med. Ctr.

Citations

  • 134 S. Ct. 941
  • 187 L. Ed. 2d 809
  • 82 U.S.L.W. 3406
  • 571 U.S. 1144
  • 2014 WL 102760
  • 2014 U.S. LEXIS 213

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • explaining that pharmaceutical companies have valid reasons for communicating with each other, and concluding that evidence of such communication, without more, is not enough to establish an unlawful conspiracy
  • affirming exclusion of expert testimony where only other example of expert’s methodology was “unpublished, non-peer-reviewed working paper that [expert] co-authored during the course of this litigation”
  • \[E]xpert testimony without ... a factual foundation cannot defeat a motion for summary judgment.\
  • “[T]he argument that, [the generic manufacturer] would have incurred the risk of launching at risk or- that [it] would have won its ... suit against [the patent holder] depends on the theory that ... [the] patents were invalid or not infringed by a generic version.”
  • ANDA filed and patent suits lasting years prior to settling

Source: CourtListener parenthetical corpus (CC0).

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.